Skip to content

Public FDA record

Z-0206-2019: MyLab Seven, Model 6400

Recall record Z-0206-2019 for ESAOTE S.P.A.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0206-2019
Company in FDA record
ESAOTE S.P.A.
FDA record creation date
Oct 23, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The probe power monitoring settings have been found to be not appropriate under specific operating conditions when connected to the devices listed below. This issue may result in overheating of the probe head. The probe power monitoring settings may not be effective in specific operating conditions so that the surface of the probe head may overheat in around one minute of continuous operations. The patient may experience discomfort, reddening of epidermis and/or mild pain. To date, no patient injury has been reported with regards to this issue.

Source facts

Action
On June 11, 2018, the firm notified IH 6-18 probe customers of the product issue through a Field Safety Notice. The letter described the issue and stated that Esaote would provide and install a corrective software update for each affected unit at no cost to the customer. Until the customer receives the corrective software update, customer is requested to refrain from use of the probe IH 618 in BTEI mode or any combined mode including BTEI in Pediatric, Neonatal and Intraoperative clinical applications. For all the other applications, you are requested to monitor the possible temperature rise at the surface of the probe head and immediately stop scanning if the patient notices any discomfort. As a general safety rule, it is recommended to use the probe in default settings, to keep the examination time as short as is necessary to produce a useful diagnostic result and not to hold the probe in a fixed position for any longer than is strictly necessary. Customers are requested to distribute this Field Safety Notice to all appropriate personnel in their organization and forward to all users of the systems, including others to whom they may have transferred the systems, in which case the customer is requested to provide information to Esaote regarding the new owner.
Initiated
2018-06-11
Root cause
Software design
Terminated
2020-05-12
Distribution
Worldwide distribution - US Nationwide in the states of AK, AZ, CA, IN, MO, NM, PA, SC, and TX. and countries Argentina and Australia Austria Bangladesh Belgium Brazil Bulgaria China Costa Rica Denmark Egypt Finland France Germany Greece Hong Kong Hungary Iceland India Iran Italy Japan Kuwait Mexico Netherlands Norway Paraguay Poland Portugal Russian Fed. Saudi Arabia Singapore Slovenia South Africa South Korea Spain Switzerland Taiwan Thailand Tunisia Turkey United Kingdom Utd.Arab Emir.
Recall number
Z-0206-2019
Recall status
Terminated
CDRH record ID
168041
FDA record created
2018-10-23
Recall event number
81285

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗